tirzepatide results women Before and After Results: Weight Loss Timelines (2026) Zepbound™ Weight-Loss Injections And Weight

Because Zepbound is FDA-approved, the SURMOUNT-1 trial result (22.5% mean weight loss with 15mg tirzepatide over 72 weeks) applies to it unlike compounded tirzepatide, which is not FDA-approved and has not been evaluated at that trial scale

Interestingly, a 2022 study found that Bifidobacteria are positively associated with GLP-1 in gestational diabetes and could have therapeutic benefits in these instances [8]

Both medications carry FDA safety guidelines full prescribing information is available at FDA.gov

Prior authorization typically requires 514 business days, documentation from your physician, and often involves resubmission if criteria change